Positive Results from Lexaria’s Molecular Characterization Study
Monomeric form of GLP-1 drug preserved by DehydraTECH KELOWNA, BC – Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms announces positive findings from… Read More




